TAKEDA AND PROTAGONIST ANNOUNCE SUBMISSION OF NEW DRUG APPLICATION (NDA) FOR RUSFERTIDE FOR TREATMENT OF POLYCYTHEMIA VERA (PV)

Reuters · 5d ago

Please log in to view news